Since the current study is only constricted on a radical prostatectomy sample from different Gleason scores, further studies involving PC biopsies from different patients may be able to address the TP53, SPOP and PIK3CA mutations in PC. This evidence concerns the gene PIK3CA and pachyonychia congenita.